Last reviewed · How we verify

NCT03740607

Virtual Reality for Alleviation of Peripheral IV Placement-Associated Discomfort

Status unknown NA Last updated 26 August 2021
What this trial tests

NA trial testing Virtual reality in Procedural Anxiety in 100 participants. Status unknown.

Timeline
1 March 2019
Primary endpoint
1 September 2022
15 September 2022

Quick facts

Lead sponsorBrooke Army Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingdouble
Primary purposetreatment
Enrollment100
Start date1 March 2019
Primary completion1 September 2022
Estimated completion15 September 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brooke Army Medical Center

Who can join

Adults 18 to 89, any sex, with Procedural Anxiety or Procedural Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Immersive virtual reality (iVR) has been used successfully to manage pain with distraction. It is a non-invasive treatment modality unassociated with worrisome well-known side effects typically seen when opioids and NSAIDS are used, and has previously been used safely in place of analgesia during dressing changes and burn care. This study investigates whether iVR can be useful as a stand-alone option to manage the pain associated with placement of peripheral intravenous (PIV) catheters in adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

Other recruiting trials for Procedural Anxiety

Currently open trials in the same condition.

Other Brooke Army Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03740607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing